Nucleoprotein Immune Complexes and Interferon in Diffuse Neuropsychiatric SLE

弥漫性神经精神 SLE 中的核蛋白免疫复合物和干扰素

基本信息

  • 批准号:
    7238549
  • 负责人:
  • 金额:
    $ 20.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2009-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The cause(s) of neuropsychiatric systemic lupus erythematosus (NPSLE) remains an enigma. Although numerous reports of associations between specific autoantibodies and CNS manifestations have been published, serum levels of none of these autoantibodies has consistently shown a high degree of sensitivity and specificity for NPSLE. Recently it has been demonstrated that immune complexes containing nucleoproteins become internalized and stimulate Toll Like Receptors (TLRs) to produce type 1 interferon (IFN). IFN has previously been implicated in NPSLE and high concentrations of IFN are known to cause neuropsychiatric symptoms similar to NPSLE. We therefore hypothesize that cell death coupled with the release of nucleoproteins results in the formation of immune complexes that stimulate TLRs to produce high local concentrations of type 1 IFN (and perhaps other cytokines) in the central nervous system (CNS) thereby causing NPSLE. The specific aims of the proposal are: To compare the frequency and activity of interferogenic (IFG) complexes in the serum (and CSF) of patients with and without NPSLE. The ability of serum from NPSLE and non NPSLE, matched for activity and other parameters to stimulate IFN and other inflammatory cytokines from mixed peripheral blood mononuclear cells as well as from cultured human microglia will be compared. A requirement for apoptotic or necrotic cells as a source of antigens will be tested and the ability of NPSLE serum to induce both cell death of neuronal targets followed by IFG immune complex formation will be examined. To determine the autoantibody specificities, nature of the antigens and TLR pathway responsible for the IFG activity. The autoantigens, their nucleic acid composition will be defined by immunochemical techniques and mass spectrometry as required. The cellular origin of cytokines will be determined by positive and negative selection. Identification of specific TLRs will be achieved by selective inhibition of endosomal TLR using oligonucleotides or siRNA. These studies are expected to lead to a new understanding of the pathogenesis of NPSLE that accounts for both autoantibodies with 'cytotoxic' function as well as autoantibodies that form nucleoprotein complexes that are now known to stimulate IFN and other pro-inflammatory and neuromodulatory cytokines. The cause of most cases of lupus affecting the brain is unknown, but there is good evidence to suggest that certain types of antibodies may play a role. Here, we test the idea that the sequential action of different antibodies that cause tissue injury followed by antibodies that capture antigens and enter the cell, causes the release of proteins called cytokines that alter brain function.
描述(由申请人提供):神经精神系统性红斑狼疮(NPSLE)的病因仍然是一个谜。尽管已经发表了许多关于特异性自身抗体与CNS表现之间的相关性的报道,但这些自身抗体的血清水平均未一致地显示出NPSLE的高度敏感性和特异性。最近已经证明,含有核蛋白的免疫复合物被内化并刺激Toll样受体(TLR)产生1型干扰素(IFN)。干扰素先前已被牵连在NPSLE和高浓度的干扰素是已知的,导致类似于NPSLE的神经精神症状。因此,我们假设,细胞死亡加上释放的核蛋白导致免疫复合物的形成,刺激TLR产生高浓度的1型IFN(和其他细胞因子)在中枢神经系统(CNS),从而导致NPSLE。该提案的具体目的是:比较有和没有NPSLE患者血清(和CSF)中干扰素(IFG)复合物的频率和活性。将比较来自NPSLE和非NPSLE的血清在活性和其它参数上匹配的刺激来自混合的外周血单核细胞以及来自培养的人小胶质细胞的IFN和其它炎性细胞因子的能力。将测试对凋亡或坏死细胞作为抗原来源的需求,并将检查NPSLE血清诱导神经元靶细胞死亡以及随后IFG免疫复合物形成的能力。确定自身抗体特异性、抗原性质和负责IFG活性的TLR途径。根据需要,将通过免疫化学技术和质谱法确定自身抗原及其核酸组成。细胞因子的细胞来源将通过阳性和阴性选择来确定。特异性TLR的鉴定将通过使用寡核苷酸或siRNA选择性抑制内体TLR来实现。这些研究预计将导致对NPSLE发病机制的新理解,其解释了具有“细胞毒性”功能的自身抗体以及形成核蛋白复合物的自身抗体,所述核蛋白复合物现在已知刺激IFN和其他促炎性和神经调节性细胞因子。大多数狼疮影响大脑的原因尚不清楚,但有很好的证据表明某些类型的抗体可能起作用。在这里,我们测试的想法,不同的抗体,导致组织损伤,其次是抗体,捕获抗原和进入细胞的顺序行动,导致释放的蛋白质称为细胞因子,改变大脑功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Keith B. Elkon其他文献

The onset of Fas expression parallels the acquisition of CD8 and CD4 in fetal and adult αβ thymocytes
Fas 表达的开始与胎儿和成人 αβ 胸腺细胞中 CD8 和 CD4 的获得平行
  • DOI:
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    0
  • 作者:
    S. Andjelic;J. Drappa;E. Lacy;Keith B. Elkon;Janko Nikoiić
  • 通讯作者:
    Janko Nikoiić
HLA antigen frequencies in systemic vasculitis: increase in HLA-DR2 in Wegener's granulomatosis.
系统性血管炎中的 HLA 抗原频率:韦格纳肉芽肿病中 HLA-DR2 增加。
  • DOI:
    10.1002/art.1780260118
  • 发表时间:
    1983
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Keith B. Elkon;Keith B. Elkon;David C. Sutherland;Andrew J. Rees;Graham R. V. Hughes;J. R. Batchelor
  • 通讯作者:
    J. R. Batchelor
The inhibition of protein synthesis by IgG containing anti-ribosome P autoantibodies from systemic lupus erythematosus patients.
系统性红斑狼疮患者含有抗核糖体 P 自身抗体的 IgG 对蛋白质合成的抑制。
  • DOI:
  • 发表时间:
    1988
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Dennis W. Stagey;Susan Skelly;Thomas Watson;Keith B. Elkon;Herbert Weissbach;N. Brot
  • 通讯作者:
    N. Brot
The (Orf)ull truth about IRF5 and type I interferons in SLE
关于系统性红斑狼疮中 IRF5 和 I 型干扰素的完整真相
  • DOI:
    10.1038/s41584-020-0472-7
  • 发表时间:
    2020-07-24
  • 期刊:
  • 影响因子:
    32.700
  • 作者:
    Keith B. Elkon;Tracy A. Briggs
  • 通讯作者:
    Tracy A. Briggs
Aspirin meets cGAS
阿司匹林与 cGAS 相遇
  • DOI:
    10.1038/s41584-019-0205-y
  • 发表时间:
    2019-03-26
  • 期刊:
  • 影响因子:
    32.700
  • 作者:
    Keith B. Elkon
  • 通讯作者:
    Keith B. Elkon

Keith B. Elkon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Keith B. Elkon', 18)}}的其他基金

cGAMP as an immunotransmitter of the interferon response to UV light
cGAMP 作为干扰素对紫外线反应的免疫递质
  • 批准号:
    10215860
  • 财政年份:
    2021
  • 资助金额:
    $ 20.11万
  • 项目类别:
Mechanisms of end organ damage in novel polygenic lupus models
新型多基因狼疮模型的终末器官损伤机制
  • 批准号:
    10007264
  • 财政年份:
    2019
  • 资助金额:
    $ 20.11万
  • 项目类别:
Link between Retroelements, Ro and Interferon Biology in Lupus
狼疮中逆转录元素、Ro 和干扰素生物学之间的联系
  • 批准号:
    9378686
  • 财政年份:
    2017
  • 资助金额:
    $ 20.11万
  • 项目类别:
Mechanisms of Ultraviolet Inflammation in Lupus
狼疮紫外线炎症的机制
  • 批准号:
    8769410
  • 财政年份:
    2014
  • 资助金额:
    $ 20.11万
  • 项目类别:
Agonists and Antagonists of Neuropsychiatric Lupus
神经精神狼疮的激动剂和拮抗剂
  • 批准号:
    7696866
  • 财政年份:
    2009
  • 资助金额:
    $ 20.11万
  • 项目类别:
Agonists and Antagonists of Neuropsychiatric Lupus
神经精神狼疮的激动剂和拮抗剂
  • 批准号:
    8145623
  • 财政年份:
    2009
  • 资助金额:
    $ 20.11万
  • 项目类别:
Agonists and Antagonists of Neuropsychiatric Lupus
神经精神狼疮的激动剂和拮抗剂
  • 批准号:
    8278629
  • 财政年份:
    2009
  • 资助金额:
    $ 20.11万
  • 项目类别:
Nucleoprotein Immune Complexes and Interferon in Diffuse Neuropsychiatric SLE
弥漫性神经精神 SLE 中的核蛋白免疫复合物和干扰素
  • 批准号:
    7393201
  • 财政年份:
    2007
  • 资助金额:
    $ 20.11万
  • 项目类别:
Apoptotic Cells As Immunogens In SLE
凋亡细胞作为系统性红斑狼疮的免疫原
  • 批准号:
    6653251
  • 财政年份:
    2001
  • 资助金额:
    $ 20.11万
  • 项目类别:
Apoptotic Cells as Immunogens in SLE
凋亡细胞作为系统性红斑狼疮的免疫原
  • 批准号:
    7103193
  • 财政年份:
    2001
  • 资助金额:
    $ 20.11万
  • 项目类别:

相似海外基金

Covid-19 continuity grant addendum for Industrial scale, novel, closed loop Aluminium waste treatment plant
Covid-19 工业规模、新型闭环铝废物处理厂连续性拨款附录
  • 批准号:
    72529
  • 财政年份:
    2020
  • 资助金额:
    $ 20.11万
  • 项目类别:
    Feasibility Studies
Experimental Particle Physics: 2016 Equipment Request to the Particle Physics Grants Panel: Addendum to the Consolidated Grant Award (ST/N000358/1)
实验粒子物理:2016 年向粒子物理资助小组提出的设备请求:综合资助奖附录 (ST/N000358/1)
  • 批准号:
    ST/P005942/1
  • 财政年份:
    2017
  • 资助金额:
    $ 20.11万
  • 项目类别:
    Research Grant
Experimental Particle Physics: Equipment Request to the STFC Particle Physics Grants Panel: Addendum to the Consolidated Grant Award (ST/N000358/1)
实验粒子物理:向 STFC 粒子物理资助小组提出的设备请求:综合资助奖附录 (ST/N000358/1)
  • 批准号:
    ST/N001176/1
  • 财政年份:
    2015
  • 资助金额:
    $ 20.11万
  • 项目类别:
    Research Grant
Experimental Particle Physics: Equipment Request to the STFC Particle Physics Grants Panel: Addendum to the Consolidated Grant Award (ST/K001205/1)
实验粒子物理:向 STFC 粒子物理资助小组提出的设备请求:综合资助奖附录 (ST/K001205/1)
  • 批准号:
    ST/L003171/1
  • 财政年份:
    2013
  • 资助金额:
    $ 20.11万
  • 项目类别:
    Research Grant
Equipment addendum to Glasgow PPE CG
格拉斯哥 PPE CG 设备附录
  • 批准号:
    ST/L001063/1
  • 财政年份:
    2012
  • 资助金额:
    $ 20.11万
  • 项目类别:
    Research Grant
2012 Consolidated Grant Supplement: Addendum to the Consolidated Grant Award (ST/K001205/1)
2012 年综合赠款补充:综合赠款奖附录 (ST/K001205/1)
  • 批准号:
    ST/M000680/1
  • 财政年份:
    2012
  • 资助金额:
    $ 20.11万
  • 项目类别:
    Research Grant
Addendum to HIV Active and Passive Clinical Material Manufacturing
HIV 主动和被动临床材料制造附录
  • 批准号:
    8947161
  • 财政年份:
    2008
  • 资助金额:
    $ 20.11万
  • 项目类别:
SGER: DHS and NSF Collaboration: Addendum to NC START National Household Survey
SGER:DHS 和 NSF 合作:NC START 全国家庭调查附录
  • 批准号:
    0647736
  • 财政年份:
    2006
  • 资助金额:
    $ 20.11万
  • 项目类别:
    Standard Grant
"ADDENDUM TO EDIC: GENETIC STUDIES OF DIABETES"
“EDIC 附录:糖尿病的遗传学研究”
  • 批准号:
    7206669
  • 财政年份:
    2004
  • 资助金额:
    $ 20.11万
  • 项目类别:
Addendum to EDIC: Genetic Studies of Diabetes
EDIC 附录:糖尿病的遗传学研究
  • 批准号:
    7041753
  • 财政年份:
    2003
  • 资助金额:
    $ 20.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了